EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mortality From Amyotrophic Lateral Sclerosis in Finland 1987–2022

Milla Laine iD, Jani Raitanen, Anssi Auvinen iD

European Journal of Neurology · 2026-04 · 33 (4)

DOI: 10.1111/ene.70586 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, online erschienen am 05.04.2026. Verfasst von Milla Laine und 2 weiteren Autor:innen. Beteiligte Einrichtung: Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. We assessed changes in the mortality from ALS in Finland from 1987 to 2022.

Methods

Numbers of deaths caused by ALS (ICD‐10 code G12.2) and population sizes by sex, age group, and year were obtained from Statistics Finland. Crude and age‐standardized mortality rates were calculated. The annual percentage change was estimated using Poisson regression, and joinpoint regression was used to identify changes in trend during the study period.

Results

Mortality from ALS increased in Finland from 1987 to 2022. The age‐standardized ALS mortality in the entire population was 2.24/100,000 in 1987 and 4.21/100,000 in 2022. The male: female ratio in mortality was 1.18. The age‐standardized mortality increased on average by 1.7% (95% CI 1.5%–2.0%) annually. In men, the age‐standardized mortality increased on average by 1.2% (95% CI 0.9%–1.6%) annually and in women by 2.0% (95% CI 1.6%–2.3%). The largest increase occurred in the oldest age group (70+ years), with an average annual increase of 2.4% (95% CI 2.0%–2.8%). In joinpoint regression, no changes in trend were identified overall or in men, but in women, the annual percentage change (APC) was 5.5% (95% CI 3.0%–8.0%) in 1987–1997 and 1.0% (95% CI 0.5%–1.4%) during 1997–2022.

Conclusion

Similar to some other countries, mortality from ALS has increased in Finland, nearly doubling in 35 years. Further research on possible reasons is needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisFinlandHumansFemaleMaleAgedMiddle AgedAdultAged, 80 and overAge Distribution

Stichwörter der Autor:innen

Finlandamyotrophic lateral sclerosisepidemiologymortalitymotor neuron disease

Autor:innen und Institutionen

  • Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland.
  • Tampere University, Faculty of Social Sciences, Unit of Health Sciences, Tampere, Finland.
  • UKK Institute for Health Promotion Research, Tampere, Finland.

ORCID-Profile: Milla Laine, Anssi Auvinen

Zitieren

APA

Laine, M., Raitanen, J., & Auvinen, A. (2026). Mortality From Amyotrophic Lateral Sclerosis in Finland 1987–2022. European Journal of Neurology, 33(4). https://doi.org/10.1111/ene.70586

Vancouver

Laine M, Raitanen J, Auvinen A. Mortality From Amyotrophic Lateral Sclerosis in Finland 1987–2022. European Journal of Neurology. 2026;33(4). doi:10.1111/ene.70586

BibTeX
@article{Laine2026,
  author = {Laine, Milla and Raitanen, Jani and Auvinen, Anssi},
  title = {Mortality From Amyotrophic Lateral Sclerosis in Finland 1987–2022},
  journal = {European Journal of Neurology},
  year = {2026},
  volume = {33},
  number = {4},
  doi = {10.1111/ene.70586}
}
Kostenlos starten →